The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

Journal of Psychopharmacology

Volumn 25, Issue 4, 2011, Pages 550-564

  Ruiz Medina, Jessica ^a   Ledent, Catherine ^b   Carretón, Olga ^a   Valverde, Olga ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

A2a adenosine receptors; astrocytes; MDMA; microglia; neurotoxicity; reinforcement

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADENOSINE A2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ASTROCYTOSIS; BODY TEMPERATURE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; HYPERTHERMIA; IMMUNOFLUORESCENCE; INSTRUMENTAL CONDITIONING; LOCOMOTION; MICROGLIA; MOTOR COORDINATION; MOUSE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REINFORCEMENT;

EID: 79953179375     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110389210     Document Type: Article

References (73)

1. Alsene K., Deckert J., Sand P. and de Wit H. (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28: 1694-1702. (Pubitemid 41070870)
2. Arolfo MP, Yao L., Gordon AS, Diamond I. and Janak P. (2004) Ethanol operant self-administration in rats is regulated by adenosine A2a receptors. Alcohol Clin Exp Res 28: 1308-1316. (Pubitemid 39238288)
3. Bailey A., Davis L., Lesscher HM, Kelly MD, Ledent C., Hourani SM, et al. (2004) Enhanced morphine withdrawal and mu-opioid receptor G-protein coupling in A2a adenosine receptor knockout mice. J Neurochem 362: 562-568.
4. Barraco RA, Helfman CC and Anderson GF (1996) Augmented release of serotonin by adenosine A2a receptor activation and desensitization by CGS 21680 in the rat nucleus tractus solitarius. Brain Res 733: 155-161. (Pubitemid 26308592)
5. Barros RC, Branco LG and Cárnio EC (2005) Respiratory and body temperature modulation by adenosine A1 receptors in the anteroventral preoptic region during normoxia and hypoxia. Respir Physiol Neurobiol 153: 115-125. (Pubitemid 44279539)
6. Beardsley PM, Balster RL and Harris LS (1986) Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 18: 149-157. (Pubitemid 16002930)
7. Berrendero F., Castañé A., Ledent C., Parmentier M., Maldonado R. and Valverde O. (2003) Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice. Eur J Neurosci 17: 315-324. (Pubitemid 36459511)
8. Bilkei-Gorzo A., Racz I., Valverde O., Otto M., Michel K., Sastre M., et al. (2005) Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci 102: 15670-15675. (Pubitemid 41528114)
9. Bilsky EJ, Hubbell CL, Delconte JD and Reid LD (1991) MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids. Pharmacol Biochem Behav 40: 443-447.
10. Bilsky EJ, Montegut MJ, Nichols ML and Reid LD (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59: 215-220. (Pubitemid 28053701)
11. Brown RM and Short JL (2008) Adenosine A (2A) receptors and their role in drug addiction. J Pharm Pharmacol 60: 1409-1430.
12. Brown RM, Short JL, Cowen MS, Ledent C. and Lawrence AJ (2009) A differential role for the adenosine A2A receptor in opiate reinforcement vs. opiate-seeking behavior. Neuropsychopharmacology 34: 844-856.
13. Bura SA, Nadal X., Ledent C., Maldonado R. and Valverde O. (2008) A2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury. Pain 140: 95-103.
14. Cadet JL, Krasnova IN, Jayanthi S. and Lyles J. (2007) Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11: 183-202.
15. Cadieux JS, Leclerc P., St- Onge M., Dussault AA, Laflamme C., Picard S., et al. (2005) Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal. J Cell Sci 118: 1437-1447. (Pubitemid 40585124)
16. Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E. and Di Chiara G. (2005) Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core. Brain Res 1055: 143-148. (Pubitemid 41224238)
17. Cami J., Farré M., Mas M., Roset PN, Poudevida S., Mas A., et al. (2000) Human pharmacology of 3,4- methylenedioxymethamphetamine ("ecstasy"). psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455-466. (Pubitemid 30463762)
18. Castañé A., Soria G., Ledent C., Maldonado R. and Valverde O. (2006) Attenuation of nicotine induced rewarding effects in A2A knockout mice. Neuropharmacology 51: 631-640. (Pubitemid 44215968)
19. Chen JF, Beilstein M., Xu YH, Turner TJ, Moratalla R., Standaert DG, et al. (2000) Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A2A adenosine receptors. Neuroscience 97: 195-204. (Pubitemid 30195889)
20. Coupar IM and Tran BL (2002) Effects of adenosine agonists on consumptive behavior and body temperature. J Pharm Pharmacol 54: 289-294. (Pubitemid 34150065)
21. Dalpiaz A. and Manfredini S. (2002) Adenosine A (1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system. Curr Med Chem 9: 1923-1937. (Pubitemid 35230259)
22. Deckert J., Nothen MM, Franke P., Delmo C., Fritze J., Knapp M., et al. (1998) Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiat 3: 81-85. (Pubitemid 28045190)
23. Devlin RJ and Henry JA (2008) Clinical review: Major consequences of illicit drug consumption. Crit Care 12: 202.
24. Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, et al. (2008 a) Role of dopamine transporters in the behavioral effects of 3,4 methylenedioxymethamphetamine (MDMA) in nonhuman primates. Psychopharmacology (Berl) 205: 337-347.
25. Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R., Traynor JR, et al. (2008 b) A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3, 4-methylenedioxymethamphetamine in the mouse. Neuroscience 151: 533-543.
26. Ferré S., Fredholm BB, Morelli M., Popoli P. and Fuxe K. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20: 482-487. (Pubitemid 27421712)
27. Ferré S., Quiroz C., Woods AS, Cunha R., Popoli P., Ciruela F., et al. (2008) An update on Adenosine A2a-Dopamina D2 receptor interactions. Implications for the function of G protein-coupled receptors. Curr Pharm Des 14: 1468-1474. (Pubitemid 351997812)
28. Feuerstein TJ, Bar KI and Lücking CH (1988) Activation of A1 adenosine receptors decreases the release of serotonin in the rabbit hippocampus, but not in the caudate nucleus. Naunyn Schmiedebergs Arch Pharmacol 1338: 664-670. (Pubitemid 19030095)
29. Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, et al. (1992) Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Mol Brain Res 14: 186-195.
30. Franklin K. and Paxinos G. (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
31. Fredholm BB, Abbracchio MP, Burnstock G., Daly JW, Harden TK, Jacobson KA, et al. (1994) VI. Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 186-195.
32. Fredholm BB, Ap IJ, Jacobson KA, Klotz KN and Linden J. (2001 a) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552. (Pubitemid 33136237)
33. Fredholm BB, Irenius E., Kull B. and Schulte G. (2001 b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61: 443-448. (Pubitemid 32168226)
34. Glass M. and Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17: 5327-5333.
35. Goñi-Allo B., Mathuna O., Segura M., Puerta E., Lasheras B., et al. (2008) The relationship between core body temperature and 3,4- methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. Psychopharmacology (Berl) 197: 263-278.
36. Green AR, Mechan AO, Elliott JM, O'Shea E. and Colado MI (2003) The pharmacology and clinical pharmacology of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 53: 463-450.
37. Han DD and Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6.
38. Hasko G., Pacher P., Vizi ES and Illes P. (2005) Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26: 511-516. (Pubitemid 41338561)
39. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277: 18091-18097. (Pubitemid 34967623)
40. Kalant H. (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Addiction 165: 917-928. (Pubitemid 34028233)
41. Koch S. and Galloway MP (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104: 135-146. (Pubitemid 27196470)
42. Lamb RJ and Griffiths RR (1987) Self-injection of d,1-3,4- methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology (Berl) 91: 268-272. (Pubitemid 17018090)
43. Ledent C., Vaugeois JM, Schiffmann SN, Pedrazzini T., El Yacoubi M., Vanderhaeghen JJ, et al. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674-678. (Pubitemid 27366438)
44. Le Moine C., Svenningsson P., Fredholm BB and Bloch B. (1997) Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. J Neurosci 17: 8038-8048. (Pubitemid 27426239)
45. Lile JA, Ross JT and Nader MA (2005) A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug Alcohol Depend 78: 135-140. (Pubitemid 40544600)
46. Lyles J. and Cadet JL (2003) Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev 42: 155-168. (Pubitemid 36549174)
47. Moreau JL and Huber G. (1999) Central adenosine A(2A) receptors: an overview. Brain Res Brain Res Rev 31: 65-82. (Pubitemid 30009614)
48. Noble F. and Cox BM (1997) The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. J Pharmacol Exp Ther 283: 557-565. (Pubitemid 27514611)
49. Okada M., Kawata Y., Kiryu K., Mizuno K., Wada K., Tasaki H., et al. (1997) Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J Neurochem 69: 2581-2588. (Pubitemid 27495446)
50. Ratzenboeck E., Saria A., Kriechbaum N. and Zernig G. (2001) Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62: 138-144. (Pubitemid 32260853)
51. Ricaurte GA, Yuan J., Hatzidimitriou G., Cord BJ and McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 297: 2260-2263.
52. Roman V., Keijser JN, Luiten PG and Meerlo P. (2008) Repetitive stimulation of adenosine A1 receptors in vivo: changes in receptor numbers, G-proteins and A1 receptor agonist-induced hypothermia. Brain Res 1191: 69-74.
53. Rosin DL, Robeva A., Woodard RL, Guyenet PG and Linden J. (1998) Immunohistochemical localization of adenosine A2a receptors in the rat central nervous system. J Comp Neurol 401: 163-186. (Pubitemid 28481960)
54. Salzmann J., Marie-Claire C., Le Guen S., Roques BP and Noble F. (2003) Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br J Pharmacol 140: 831-838. (Pubitemid 37464064)
55. Saura J., Angulo E., Ejarque A., Casadó V., Tusell JM, Moratalla R., et al. (2005) Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 95: 919-929. (Pubitemid 41713478)
56. Schenk S., Gittings D., Johnstone M. and Daniela E. (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 169: 21-27. (Pubitemid 37088610)
57. Schiffmann SN, Fisone G., Moresco R., Cunha RA and Ferré S. (2007) Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83: 277-292. (Pubitemid 350110609)
58. Short JL, Ledent C., Drago J. and Lawrence AJ (2006) Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Neuropsychopharmacology 31: 525-534. (Pubitemid 43276968)
59. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., et al. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J 17: 886-897. (Pubitemid 28077643)
60. Soria G., Castañé A., Berrendero F., Ledent C., Parmentier M., Maldonado R., et al. (2004) Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. Eur J Neurosci 20: 2203-2213. (Pubitemid 39331141)
61. Soria G., Castañé A., Ledent C., Parmentier M., Maldonado R., et al. (2006) The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31: 978-987.
62. Soria G., Mendizabal V., Tourino C., Robledo P., Ledent C., Parmentier M., et al. (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30: 1670-1680. (Pubitemid 43086024)
63. Svenningsson P., Le Moine C., Kull B., Sunahara R., Bloch B. and Fredholm BB (1997) Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80: 1171-1185. (Pubitemid 27359801)
64. Thomas DM, Francescutti-Verbeem DM and Kuhn DM (2008) Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. J Neurochem 106: 696-705.
65. Trigo JM, Panayi F., Soria G., Maldonado R. and Robledo P. (2006) A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology (Berl) 184: 212-220. (Pubitemid 43083658)
66. Trigo JM, Renoir T., Lanfumey L., Hamon M., Lesch KP, Robledo P., et al. (2007) 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry 62: 669-679. (Pubitemid 47314373)
67. Touriño C., Ledent C., Maldonado R. and Valverde O. (2008) CB1 cannabinoid receptor modulates 3, 4-methylenedioxymethamphetamine acute responses and reinforcement. Biol Psychiatry 63: 1030-1038. (Pubitemid 351636293)
68. Touriño C., Zimmer A. and Valverde O. (2010) THC prevents MDMA neurotoxicity in mice. PloS One 10: 5: e 9143.
69. Volkow ND (2006) Stimulant medications: how to minimize their reinforcing effects ? Am J Psychiatry 163: 359-361. (Pubitemid 44469374)
70. Wang JH, Short J., Ledent C., Lawrence AJ and van den Buuse M. (2003) Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2a receptor. Behav Brain Res 143: 201-207. (Pubitemid 36937165)
71. Wardas J. (2002) Neuroprotective role of adenosine in the CNS. Pol J Pharmacol 54: 313-326.
72. Yao L., Arolfo MP, Dohrman D., Peidong F., Fuchs S., Janak P., et al. (2002) β γdimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109: 733-743. (Pubitemid 34722269)
73. Yao L., Peidong F., Zhan J., Mailliard S., Gordon A. and Diamond I. (2003) Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-β γ dimers. Proc Natl Acad Sci 100: 14379-14384. (Pubitemid 37499245)